参考文献/References:
[1] 王 硕. 脑血管痉挛防治神经外科专家共识[J]. 中国卒中
杂志，2008，3（5）：356-362.
[2] 刘承基，凌 锋. 脑脊髓血管外科学[M]. 北京：中国科学
技术出版社，2013. 124-149.
[3] Mikeladze KG, éliava ShSh, Shekhtman OD, et al. Intra-
arterial injection of verapamil in treatment of cerebral vaso-
spasm in a patient with acute subarachnoid hemorrhage
from an aneurysm: case report [J]. Zh Vopr Neirokhir Im N
N Burdenko, 2013, 77(4):57-60.
[4] Liu J, Yao GE, Zhou HD, et al. Clinical investigation of
fasudil for the prevention of cerebral vasospasm in extra-
cranial carotid artery stenting [J]. Cell Biochem Biophys,
2014, 68(1): 185-188.
[5] Haley EC, Kassell NF, Apperson-Hansen C, et al. A rando-
mized, double-blind, vehicle-controlled trial of tirilazad
mesylate in patients with aneurysmal subarachnoid hemorr-
hage: a cooperative study in North America [J]. J Neurosurg,
1997, 86(3): 467-474.
[6] Munakata A, Ohkuma H, Nakano T, et al. Effect of a free
radical scavenger, edaravone, in the treatment of patients
with aneurismal subarachnoid hemorrhage [J]. Neurosur-
gery, 2009, 64(3): 423-429.
[7] Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces
vasospasm after aneurysmal subarachnoid hemorrhage:
results of a pilot randomized clinical trial [J]. Stroke, 2005,
36(9): 2024-2026.
[8] Vajkoczy P, Meyer B, Weidauer S, et al. Clazosentan (AXV-
034343), a selective endothelin A receptor antagonist, in the
prevention of cerebral vasospasm following severe aneury-
smal subarachnoid hemorrhage: results of a randomized,
double-blind, placebo-controlled, multicenter phase Ⅱa
study [J]. J Neurosurg, 2005, 103(1): 9-17.
[9] Sun BL, Zhang SM, Xia ZL, et al. L-arginine improves
cerebral blood perfusion and vasomotion of microvessels
following subarachnoid hemorrhage in rats [J]. Clin Hemor-
heol Microcirc, 2003, 29(3-4): 391-400.
[10] 隋 璐，沈 薇，李玉芳，等. 甲基强的松龙对兔实验性脑
血管痉挛的作用[J]. 中国实用神经疾病杂志，2008，11
（2）：44-46.
[11] Handa Y, Hayashi M, Takeuchi H, et al. Effect of cyclospo-
rine on the development of cerebral vasospasm in a primate
model [J]. Neurosurgery, 1991, 28(3): 380-385.
[12] Suzuki Y, Shibuya M, Satoh S, et al. Safety and efficacy of
fasudil monotherapy and fasudil-ozagrel combination
therapy in patients with subarachnoid hemorrhage: sub-
analysis of the post-marketing surveillance study [J]. Neurol
Med Chir (Tokyo), 2008, 48(6): 241-247.
[13] Honda Y, Minato H, Fujitani B, et al. Alacepril, an angio-
tensin-converting enzyme inhibitor, prevents cerebral
vasospasm in subarachnoid hemorrhage model in rats [J].
Methods Find Exp Clin Pharmacol, 1997, 19(10): 699-706.
[14] Wickman G, Lan C, Vollrath B. Functional roles of the rho/
rho kinase pathway and protein kinase C in the regulation
of cerebrovascular constriction mediated by hemoglobin:
relevance to subarachnoid hemorrhage and vasospasm [J].
Circ Res, 2003, 92(7): 809-816.
[15] Tseng MY, Hutchinson PJ, Richards HK, et al. Acute
systemic erythropoietin therapy to reduce delayed ischemic
deficits following aneurysmal subarachnoid hemorrhage: a
PhaseⅡrandomized, double-blind, placebo-controlled trial
[J]. J Neurosurg, 2009, 111(1): 171-180.
[16] Kwan AL, Lin CL, Wu CS, et al. Delayed administration of
the K+ channel activator cromakalim attenuates cerebral
vasospasm after experimental subarachnoid hemorrhage [J].
Acta Neurochir (Wien), 2000, 142(2): 193-197.
[17] Zubkov AY, Aoki K, Parent AD, et al. Preliminary study of
the effects of caspase inhibitors on vasospasm in dog pene-
trating arteries [J]. Life Sci, 2002, 70(25): 3007-3018.
[18] Yarad EA, Hammond NE. Intravenous magnesium therapy
in adult patients with an aneurysmal subarachnoid haemorr-
hage: a systematic review and meta-analysis [J]. Aust Crit
Care, 2013, 26(3): 105-117.
[19] Odom MJ, Zuckerman SL, Mocco J. The role of magnesium
in the management of cerebral vasospasm [J]. Neurol Res
Int, 2013, 2013: 914-943.
[20] Fraticelli AT, Cholley BP, Losser MR, et al. Milrinone for
the treatment of cerebral vasospasm after aneurysmal sub-
arachnoid hemorrhage [J]. Stroke, 2008, 39(3): 893-898.
[21] Toyoda K, Faraci FM, Watanabe Y, et al. Gene transfer of
calcitonin gene-related peptide prevents vasoconstriction
after subarachnoid hemorrhage [J]. Circ Res, 2000, 87(9):
818-824.
[22] Onoue H, Tsutsui M, Smith L, et al. Expression and function
of recombinant endothelial nitric oxide synthase gene in
canine basilar artery after experimental subarachnoid he-
morrhage [J]. Stroke, 1998, 29(9): 1959-1965.
[23] 张宏伟，鲍圣德，孙丕通，等. 中药川芎嗪对蛛网膜下腔出
血后脑血管痉挛的实验研究[J]. 中国微侵袭神经外科杂
志，2008，13（3）：124-127.
相似文献/References:
[1]周路桥 罗富强 彭 虎 邱成元 刘 苏 蒋国辉 田 强 罗荣武.皮瓣塌陷综合征患者颅骨修补术后继发蛛网膜下腔出血1例[J].中国临床神经外科杂志,2015,(11):704.[doi:10.13798/j.issn.1009-153X.2015.11.022]
[2]余龙洋 李亚楠 周 宇 戴冬伟 曹依群 岳志健.垂体腺瘤经蝶术后并发蛛网膜下腔出血的临床分析
（附6例报道）[J].中国临床神经外科杂志,2016,(06):372.[doi:10.13798/j.issn.1009-153X.2016.06.018]
[3]周 量 刘 丛 张昌伟.早期栓塞术治疗动脉瘤性蛛网膜下腔出血的疗效[J].中国临床神经外科杂志,2016,(07):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
ZHOU Liang,LIU Cong,ZHANG Chang-wei..Curative effect of early endovascular embolization on patients with ruptured intracranial aneurysms[J].,2016,(09):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
[4]朱作磊 综述 罗良生 审校.动脉瘤性蛛网膜下腔出血的预后相关因素研究进展[J].中国临床神经外科杂志,2016,(03):183.[doi:10.13798/j.issn.1009-153X.2016.03.020]
[5]廖驭国 刘胜初 钟云天 罗 捷.腰大池引流术防治颅内动脉瘤栓塞术后脑血管痉挛的临床疗效[J].中国临床神经外科杂志,2016,(02):89.[doi:10.13798/j.issn.1009-153X.2016.02.010]
LIAO Yu-guo,LIU Sheng-chu,CHU Yun-tian,et al.Effect of lumbar cistern drainage on cerebral vasospasm in patients with ruptured intracranial aneurysms after embolization[J].,2016,(09):89.[doi:10.13798/j.issn.1009-153X.2016.02.010]
[6]邹志鹏 杨 海 夏军勇 张化明 张 华 魏 恒 马江红.行血管内治疗的高龄颅内动脉瘤患者脑血管痉挛的临床分析[J].中国临床神经外科杂志,2015,(07):401.[doi:10.13798/j.issn.1009-153X.2015.07.006]
ZOU Zhi-peng,YANG Hai,XIA Jun-yong,et al.Clinical analysis of symptomatic cerebral vasospasm after endovascular treatment of ruptured cerebral aneurysms in patients of 70 and over 70 years[J].,2015,(09):401.[doi:10.13798/j.issn.1009-153X.2015.07.006]
[7]祝 源 李 俊 陈 刚 向伟楚 李国栋 赵曰圆 李欢欢 汤 伟 金二亮 马廉亭.两次DSA阴性的颅内破裂动脉瘤1例报道并文献复习[J].中国临床神经外科杂志,2015,(09):538.[doi:10.13798/j.issn.1009-153X.2015.09.009]
ZHU Yuan,LI Jun,CHEN Gang,et al.Both negative DSA findings in 1 patient with ruptured intracranial aneurysm (case report and review of literature)[J].,2015,(09):538.[doi:10.13798/j.issn.1009-153X.2015.09.009]
[8]陈 旭 吴 琳 冯达云 王举磊 秦怀洲 高国栋 张治国.头孢曲松钠对大鼠蛛网膜下腔出血后认知功能的影响[J].中国临床神经外科杂志,2015,(04):228.[doi:10.13798/j.issn.1009-153X.2015.04.012]
CHEN Xu,WU Lin,FENG Da-yun,et al.Effect of ceftriaxone on cognitive function after subarachnoid hemorrhage in the adult rats[J].,2015,(09):228.[doi:10.13798/j.issn.1009-153X.2015.04.012]
[9]刘骏辉 综述 陈谦学 审校.动脉瘤性蛛网膜下腔出血后抗血管痉挛的药物治疗[J].中国临床神经外科杂志,2016,(08):504.[doi:10.13798/j.issn.1009-153X.2016.08.024]
[10]郎胜坤 许厚银 董月青 马铁柱 孙 艳 郝芊芊 王慧敏.磁共振灌注成像评估蛛网膜下腔出血后脑血管痉挛的价值[J].中国临床神经外科杂志,2016,(09):517.[doi:10.13798/j.issn.1009-153X.2016.09.002]
LANG Sheng-kuan,XU Hou-yin,DONG Yue-qing,et al.Evaluation of cerebral vasospasm after aneurysmal subarachnoid hemorrhage by magnetic resonance perfusion weighted imaging[J].,2016,(09):517.[doi:10.13798/j.issn.1009-153X.2016.09.002]
[11]旷仁钊 唐晓平 漆 建 苟章洋.丹红注射液对大鼠蛛网膜下腔出血后脑血管痉挛的影响[J].中国临床神经外科杂志,2015,(11):683.[doi:10.13798/j.issn.1009-153X.2015.11.014]
KUANG Ren-zhao,TANG Xiao-ping,QI Jian,et al.Effects of Danhong on cerebral vasospasm after subara- chnoid hemorrhage in rats[J].,2015,(09):683.[doi:10.13798/j.issn.1009-153X.2015.11.014]
[12]李朝晖 王玉贵 张孟超 综述 赵兴利 审校.CT灌注成像在动脉瘤性蛛网膜下腔出血中的
临床应用进展[J].中国临床神经外科杂志,2016,(05):313.[doi:10.13798/j.issn.1009-153X.2016.05.021]
[13]水 涛 郭再玉 综述 马廉亭 审校.蛛网膜下腔出血后脑血管痉挛的亚低温治疗进展[J].中国临床神经外科杂志,2016,(03):185.[doi:10.13798/j.issn.1009-153X.2016.03.021]
[14]赵建伍 于耀宇 余天垒 李延良 唐 铸 桂 铮 周 欣 姬文婕.黄芪甲苷对大鼠蛛网膜下腔出血后脑血管痉挛的影响[J].中国临床神经外科杂志,2015,(06):350.[doi:10.13798/j.issn.1009-153X.2015.06.010]
ZHAO Jian-wu,YU Yao-yu,YU Tian-lei,et al.Effects of Astragaloside Ⅳ on delayed cerebral vasospasm after subarachnoid hemorrhage[J].,2015,(09):350.[doi:10.13798/j.issn.1009-153X.2015.06.010]
[15]赵乐,综述,曹毅,等.尼莫地平在aSAH治疗中的研究进展[J].中国临床神经外科杂志,2017,(02):115.[doi:10.13798/j.issn.1009-153X.2017.02.020]
[16]熊 平 唐晓平.促红细胞生成素对大鼠蛛网膜下腔出血后血管痉挛的防治作用[J].中国临床神经外科杂志,2018,(04):254.[doi:10.13798/j.issn.1009-153X.2018.04.010]
XIONG Ping,TANG Xiao-ping..Preventive and therapeutic effects of erythropoietin on cerebral vasospasm after subarachnoid hemorrhage in rats[J].,2018,(09):254.[doi:10.13798/j.issn.1009-153X.2018.04.010]
[17]陈华轩 张 渊 王 林 宋旭东 刘 毅 范润金.缺血修饰白蛋白对动脉瘤性蛛网膜下腔出血后脑血管痉挛的评估价值[J].中国临床神经外科杂志,2019,(01):26.[doi:10.13798/j.issn.1009-153X.2019.01.007]
CHEN Hua-xuan,ZHANG Yuan,WANG Lin,et al.Value of ischemia-modified albumin to assesment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage[J].,2019,(09):26.[doi:10.13798/j.issn.1009-153X.2019.01.007]
[18]黄昌恒 于耀宇 赵文可 何一川 姚自同.黄芪甲苷对大鼠蛛网膜下腔出血后迟发性脑血管痉挛的影响[J].中国临床神经外科杂志,2019,(02):98.[doi:10.13798/j.issn.1009-153X.2019.02.011]
HUANG Chang-heng,YU Yao-yu,ZHAO Wen-ke,et al.Effect of astragaloside A on delayed cerebral vasospasm in rats after subarachnoid hemorrhage[J].,2019,(09):98.[doi:10.13798/j.issn.1009-153X.2019.02.011]
[19]谭占国 黄圣明.蛛网膜下腔出血后迟发脑血管痉挛诊治新进展[J].中国临床神经外科杂志,2019,(08):505.[doi:10.13798/j.issn.1009-153X.2019.08.020]
[20]谢昌纪 周志宇 韦成聪.颅内动脉瘤破裂出血后脑血管痉挛发病机制的研究进展[J].中国临床神经外科杂志,2021,26(09):727.[doi:10.13798/j.issn.1009-153X.2021.09.026]